Price Comparison

CagriSema

Metabolic CombinationBlend

7 vendors competing

7 of 7 vendors
Prices for CagriSema by vendor
VendorPrice10mg costUpdatedActions
Eternal Peptides8.5/10
8.5/10
COA ✓Ships: USCredit/debit card · Zelle
Verification & shipping
8.5/10
COA ✓Ships: USCredit/debit card · Zelle
$89.24$104.99−15% · code peptideprices10mg package$89.24Checked aug 2, 2026Aug 2, 2026Buy CagriSema from Eternal Peptides
Durham Peptides6.5/10
6.5/10
COA ✓Ships: CanadaInterac e-Transfer
Verification & shipping
6.5/10
COA ✓Ships: CanadaInterac e-Transfer
$93.10$103.44−10% · code PEPTIDEPRICES10mg package$93.10Checked aug 7, 2026Aug 7, 2026Buy CagriSema from Durham Peptides
Hydro Research9/10
9/10
COA ✓Ships: USVisa · Mastercard
Verification & shipping
9/10
COA ✓Ships: USVisa · Mastercard
$106.25$125.00−15% · code PEPTIDEP1510mg package$106.25Checked jun 5, 2026Jun 5, 2026Buy CagriSema from Hydro Research
StrikePoint Peptides7.5/10
7.5/10
COA ✓Ships: USCard · Zelle
Verification & shipping
7.5/10
COA ✓Ships: USCard · Zelle
$108.8010mg package$108.80Checked 2 days ago2 days agoBuy CagriSema from StrikePoint Peptides
GLP-1 Research Lab8/10
8/10
COA ✓Ships: USCredit/debit card · Crypto (stablecoin)
Verification & shipping
8/10
COA ✓Ships: USCredit/debit card · Crypto (stablecoin)
$67.505mg package$135.00Checked jun 19, 2026Jun 19, 2026Buy CagriSema from GLP-1 Research Lab
Nationwide Peptides6/10
6/10
COA ✓Ships: USCredit/debit card
Verification & shipping
6/10
COA ✓Ships: USCredit/debit card
Out of stock
$89.10$99.00−10% · code peptideprices5mg package$178.20Checked aug 5, 2026Aug 5, 2026Buy CagriSema from Nationwide Peptides

Research details

CagriSema — research data

Half-lifeSemaglutide ~1 week; Cagrilintide ~7–8 days. Both dosed once weekly.
Regulatory statusPhase III (not yet approved)
NCAA D1Not listed

Overview

About CagriSema

Mechanism of action

Combination of cagrilintide (amylin agonist) and GLP-1S (GLP-1 agonist); dual mechanism targets appetite, gastric emptying, and satiety via complementary central and peripheral pathways; demonstrated greater weight loss than either alone.

Safety profile

Nausea, vomiting, diarrhea (additive GI effects vs. either alone); injection site reactions; constipation. Profile similar to GLP-1 class. · Strong Phase III data; GI side effects similar to GLP-1S; regulatory review ongoing

Storage

Stability & handling

❄️Lyophilized (powder)−20°Clong-term stable
💉Reconstituted2–8°Cwithin 30 days

Related pages

More on CagriSema

Stack & Compare

Frequently Researched Together

Research

Studies & key findings

  • Fixed-ratio combination of cagrilintide (amylin analogue) + GLP-1S (GLP-1 agonist) in a once-weekly subcutaneous injection — dual complementary mechanisms targeting satiety, gastric emptying, and energy expenditure.
  • REIMAGINE Phase 2/3 trials demonstrated ~25% mean body weight loss at 68 weeks, with significant improvements in HbA1c, waist circumference, and blood pressure.

3 peer-reviewed sources cited — clinical, preclinical, and regulatory.

Read full research →
Failed to fetch